xpovio
(Selinexor)Karyopharm Therapeutics Inc.
Usage: Xpovio (selinexor) treats adult multiple myeloma patients after prior therapies, in combination with bortezomib/dexamethasone or dexamethasone alone. Also indicated for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) after at least 2 prior systemic therapy lines.